100% imminent placement is on the cards. Up to 3 months due diligence and US$500K all up. They don't have that much cash. At current marketcap it's going to be a decent dilution.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
